Wound dressing BIOPATCH®

polyurethaneantimicrobial

In the US each year, there are an estimated 250,000 Central Line‐Associated Bloodstream Infections, with up to 33,000 deaths and a potential cost of $1 billion to the health care system.1 BIOPATCH™ is the only dressing that is designed to deliver chlorhexidine gluconate a full 360 degrees around the catheter insertion site, providing optimized coverage and protection.2,3 It is the only sponge dressing with a cleared indication for the reduction of CRBSIs in central venous and arterial catheters, with proven clinical efficacy About this Device BIOPATCH™ is a hydrophilic polyurethane absorptive foam with chlorhexidine gluconate (CHG). The foam material absorbs up to eight times its own weight in fluid, while the CHG incorporated into the dressing inhibits bacterial growth under the dressing. Chlorhexidine gluconate is a well-known antiseptic agent with broad-spectrum antimicrobial and antifungal activity Economic Evidence The cost of a catheter-related bloodstream infection (CRBSI) is higher than the price of preventing it. A single CRBSI can cost up to $45,814, on average. Chlorhexidine-impregnated sponges for arterial and central venous catheters may save money by reducing major catheter-related infections.10,11 A controlled, randomized, clinical trial consisting of 687 subjects with 1699 central venous or arterial catheter insertion sites was conducted at two centers. Results showed that the use of BIOPATCH™ had a3: 44% reduction in the incidence of local infection (p≤0.0001) 60% reduction in the incidence of catheter-related blood stream infections (p=0.026)